Liviniti的动态

Need to model drug contracts faster and more accurately? Our CXO and Founder, Nico Julian Mros, explains how the Lyfegen Drug Contracting Simulator’s advanced features can streamline and optimize your contracting processes. Explore different pricing options and contract scenarios with our solution, providing valuable support in your decision-making process. #drugpricing #healthcareinnovation #marketaccess

Weekend reading: US's 340B Drug Pricing Program, already the second largest affordable drug pricing program is spiralling out of control as the scale is growing but the benefits are not reaching the patients Read more here: https://lnkd.in/gfTgqVGC

Learn how CARBOGEN AMCIS can support you through the various clinical phases to bring your new drug from bench to market. #CDMO #PremiumCDMO #Swiss #Swissquality #drugsubstance #drugproduct #E2E

Transparency in the Maximum Fair Price (MFP) negotiations is crucial to understanding why certain medications were chosen as therapeutic alternatives over others. What was the rationale for CMS choosing some medications as therapeutic alternatives for a selected product over others? This question can have significant implications for drug accessibility and pricing strategies. Find out more by reading our latest article on our website. https://buff.ly/40FVJHu #LumanityPerspectives #IRA #MFP #MarketAccess

Our 12th annual high-cost claims and injectable drug trends analysis includes a look into the top 20 conditions and their subcategories, a special look into $5M+ claims, and more! Click on the link below to see the full report! https://lnkd.in/g__sYF4q

Only a few days left! Have you registered for our upcoming webinar on international reference pricing (IRP)? Learn why effective IRP management is crucial for thriving in today's market. Discover how Simon-Kucher’s LS Genius | IRP tool can help you navigate complex pricing dynamics and boost your Return on Sales by up to 10%. Don't miss out—secure your spot now: skp.link/0r9v #BetterMarketAccess #Pharma #IRP #SimonKucher

Are you prepared to meet the evidence needs of patients, providers, regulators, and payers? Check off the keys for a successful integrated evidence generation strategy with UBC’s Global Evidence Generation Checklist: https://hubs.li/Q030Spgr0 #PatientsFirst #RWE #RealWorldEvidence #Pharma #DrugDevelopment

GLP-1 medications have surged in popularity in 2024 and are expected to continue gaining traction in 2025. In Healthcare IT Today, Avalon’s Dr. Julie Schulz, MD, MPH, shares her outlook on the future of GLP-1 drugs.? ? Read more: https://lnkd.in/ersGZF3G?? ? #AvalonHCS #GLP1 #HealthPlans #HealthcareCosts

We are pleased to announce PrecisionCare One?, an extension of VIVIO's proven open-market specialty drug management platform to include all drugs. Read the press release: https://lnkd.in/gNs8SH76 #HealthcareInnovation #PBMDisruption #EmployerBenefits #BetterHealthOutcomes

Our 12th annual high-cost claims and injectable drug trends analysis includes a look into the top 20 conditions and their subcategories, a special look into $5M+ claims, and more! Click into the link below to see the full report! https://lnkd.in/eX9NTae4